Page last updated: 2024-11-06

4(5)-phenylimidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4(5)-phenylimidazole: tautomeric cpd; cytochrome P450 14alpha-sterol demethylase, CYP51 antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID69590
CHEMBL ID14145
SCHEMBL ID37563
MeSH IDM0102642

Synonyms (46)

Synonym
BB 0258796
4(5)-phenylimidazole
4-phenylimidazole
imidazole, 4-phenyl-
670-95-1
nsc195337
1h-imidazole, 4-phenyl-
nsc-195337
AC-907/25014360
4-phenyl imidazole
4-phenyl-1h-imidazole
inchi=1/c9h8n2/c1-2-4-8(5-3-1)9-6-10-7-11-9/h1-7h,(h,10,11
DB03254
4-phenylimidazole, 97%
4-phenylimidazole, 4-pi
bdbm24656
chembl14145 ,
5-phenyl-1h-imidazole
P0877
HMS1655B13
AKOS002286246
A22082
STK741347
5-phenylimidazole
F1918-0054
1h-imidazole, 5-phenyl-
nsc 195337
einecs 211-580-1
FT-0619408
AKOS015910541
SCHEMBL37563
mfcd00005197
SY010636
4-phenyl-imidazole
AM85871
W-104732
STR05069
DTXSID30217200
F8880-8368
bdbm50126142
CS-W016387
Q27464438
EN300-35262
PD059830
HY-W015671
8VQ67XR7XY
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (10)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 2B1Rattus norvegicus (Norway rat)IC50 (µMol)7.40007.40007.80008.2000AID38395
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)IC50 (µMol)76.78240.05373.075710.0000AID1252323; AID1350379; AID1440267; AID1440271; AID1440284; AID1440285; AID1440295; AID1453712; AID1569323; AID1616269; AID1616271; AID1713751; AID1775067; AID1798457; AID1882075; AID361932; AID728969
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)Ki4.40000.09402.37907.0000AID361931
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine/threonine-protein kinase mTORHomo sapiens (human)Kd10,000.00000.00010.59939.2000AID69097
Cytochrome P450 144Mycobacterium tuberculosis CDC1551Kd872.00000.36002.59905.3000AID1799791; AID1802600
Steroid C26-monooxygenaseMycobacterium tuberculosis CDC1551Kd169.33330.10002.59676.1000AID1799791
Steroid C26-monooxygenaseMycobacterium tuberculosis CDC1551Kd169.33330.36002.59905.3000AID1799791
Lanosterol 14-alpha demethylaseMycobacterium tuberculosis H37RvKd1.30000.20000.42001.3000AID351876
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 2B1Rattus norvegicus (Norway rat)Ks1.10001.10001.10001.1000AID184443
Cytochrome P450 1A1Rattus norvegicus (Norway rat)Ks1.70001.70001.70001.7000AID184441
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)Ks1.70001.70001.70001.7000AID184441
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (106)

Processvia Protein(s)Taxonomy
regulation of activated T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell tolerance inductionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of chronic inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of type 2 immune responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
female pregnancyIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic process to kynurenineIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
response to lipopolysaccharideIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of interleukin-10 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of interleukin-12 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
multicellular organismal response to stressIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
kynurenic acid biosynthetic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
swimming behaviorIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
'de novo' NAD biosynthetic process from tryptophanIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
protein destabilizationSerine/threonine-protein kinase mTORHomo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase mTORHomo sapiens (human)
negative regulation of macroautophagySerine/threonine-protein kinase mTORHomo sapiens (human)
phosphorylationSerine/threonine-protein kinase mTORHomo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of cell growthSerine/threonine-protein kinase mTORHomo sapiens (human)
T-helper 1 cell lineage commitmentSerine/threonine-protein kinase mTORHomo sapiens (human)
heart morphogenesisSerine/threonine-protein kinase mTORHomo sapiens (human)
heart valve morphogenesisSerine/threonine-protein kinase mTORHomo sapiens (human)
energy reserve metabolic processSerine/threonine-protein kinase mTORHomo sapiens (human)
'de novo' pyrimidine nucleobase biosynthetic processSerine/threonine-protein kinase mTORHomo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase mTORHomo sapiens (human)
inflammatory responseSerine/threonine-protein kinase mTORHomo sapiens (human)
DNA damage responseSerine/threonine-protein kinase mTORHomo sapiens (human)
cytoskeleton organizationSerine/threonine-protein kinase mTORHomo sapiens (human)
lysosome organizationSerine/threonine-protein kinase mTORHomo sapiens (human)
germ cell developmentSerine/threonine-protein kinase mTORHomo sapiens (human)
response to nutrientSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of cell sizeSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to starvationSerine/threonine-protein kinase mTORHomo sapiens (human)
response to heatSerine/threonine-protein kinase mTORHomo sapiens (human)
post-embryonic developmentSerine/threonine-protein kinase mTORHomo sapiens (human)
negative regulation of autophagySerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of lamellipodium assemblySerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of gene expressionSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of epithelial to mesenchymal transitionSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of myotube differentiationSerine/threonine-protein kinase mTORHomo sapiens (human)
macroautophagySerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of macroautophagySerine/threonine-protein kinase mTORHomo sapiens (human)
phosphorylationSerine/threonine-protein kinase mTORHomo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase mTORHomo sapiens (human)
neuronal action potentialSerine/threonine-protein kinase mTORHomo sapiens (human)
protein catabolic processSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of cell growthSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of actin filament polymerizationSerine/threonine-protein kinase mTORHomo sapiens (human)
T cell costimulationSerine/threonine-protein kinase mTORHomo sapiens (human)
ruffle organizationSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of myelinationSerine/threonine-protein kinase mTORHomo sapiens (human)
response to nutrient levelsSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to nutrient levelsSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to nutrientSerine/threonine-protein kinase mTORHomo sapiens (human)
TOR signalingSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of phosphoprotein phosphatase activitySerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to insulin stimulusSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of actin cytoskeleton organizationSerine/threonine-protein kinase mTORHomo sapiens (human)
calcineurin-NFAT signaling cascadeSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to amino acid starvationSerine/threonine-protein kinase mTORHomo sapiens (human)
multicellular organism growthSerine/threonine-protein kinase mTORHomo sapiens (human)
TORC1 signalingSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of circadian rhythmSerine/threonine-protein kinase mTORHomo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase mTORHomo sapiens (human)
response to amino acidSerine/threonine-protein kinase mTORHomo sapiens (human)
anoikisSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of osteoclast differentiationSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of translationSerine/threonine-protein kinase mTORHomo sapiens (human)
negative regulation of cell sizeSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of glycolytic processSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIISerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of translational initiationSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of lipid biosynthetic processSerine/threonine-protein kinase mTORHomo sapiens (human)
behavioral response to painSerine/threonine-protein kinase mTORHomo sapiens (human)
rhythmic processSerine/threonine-protein kinase mTORHomo sapiens (human)
oligodendrocyte differentiationSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of oligodendrocyte differentiationSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationSerine/threonine-protein kinase mTORHomo sapiens (human)
voluntary musculoskeletal movementSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of stress fiber assemblySerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of keratinocyte migrationSerine/threonine-protein kinase mTORHomo sapiens (human)
nucleus localizationSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionSerine/threonine-protein kinase mTORHomo sapiens (human)
cardiac muscle cell developmentSerine/threonine-protein kinase mTORHomo sapiens (human)
cardiac muscle contractionSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to methionineSerine/threonine-protein kinase mTORHomo sapiens (human)
negative regulation of calcineurin-NFAT signaling cascadeSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to amino acid stimulusSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to L-leucineSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to hypoxiaSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to osmotic stressSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of membrane permeabilitySerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of cellular response to heatSerine/threonine-protein kinase mTORHomo sapiens (human)
negative regulation of protein localization to nucleusSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of signal transduction by p53 class mediatorSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of transcription of nucleolar large rRNA by RNA polymerase ISerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of wound healing, spreading of epidermal cellsSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of locomotor rhythmSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of cytoplasmic translational initiationSerine/threonine-protein kinase mTORHomo sapiens (human)
negative regulation of lysosome organizationSerine/threonine-protein kinase mTORHomo sapiens (human)
positive regulation of pentose-phosphate shuntSerine/threonine-protein kinase mTORHomo sapiens (human)
cellular response to leucine starvationSerine/threonine-protein kinase mTORHomo sapiens (human)
regulation of autophagosome assemblySerine/threonine-protein kinase mTORHomo sapiens (human)
negative regulation of macroautophagySerine/threonine-protein kinase mTORHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (18)

Processvia Protein(s)Taxonomy
electron transfer activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
heme bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
indoleamine 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
metal ion bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
RNA polymerase III type 1 promoter sequence-specific DNA bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
RNA polymerase III type 2 promoter sequence-specific DNA bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
RNA polymerase III type 3 promoter sequence-specific DNA bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
TFIIIC-class transcription factor complex bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
protein kinase activitySerine/threonine-protein kinase mTORHomo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase mTORHomo sapiens (human)
protein bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
ATP bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
kinase activitySerine/threonine-protein kinase mTORHomo sapiens (human)
identical protein bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
ribosome bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
phosphoprotein bindingSerine/threonine-protein kinase mTORHomo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase mTORHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
cytosolIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
smooth muscle contractile fiberIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
stereocilium bundleIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
PML bodySerine/threonine-protein kinase mTORHomo sapiens (human)
lysosomal membraneSerine/threonine-protein kinase mTORHomo sapiens (human)
cytosolSerine/threonine-protein kinase mTORHomo sapiens (human)
Golgi membraneSerine/threonine-protein kinase mTORHomo sapiens (human)
nucleoplasmSerine/threonine-protein kinase mTORHomo sapiens (human)
cytoplasmSerine/threonine-protein kinase mTORHomo sapiens (human)
mitochondrial outer membraneSerine/threonine-protein kinase mTORHomo sapiens (human)
lysosomeSerine/threonine-protein kinase mTORHomo sapiens (human)
lysosomal membraneSerine/threonine-protein kinase mTORHomo sapiens (human)
endoplasmic reticulum membraneSerine/threonine-protein kinase mTORHomo sapiens (human)
cytosolSerine/threonine-protein kinase mTORHomo sapiens (human)
endomembrane systemSerine/threonine-protein kinase mTORHomo sapiens (human)
membraneSerine/threonine-protein kinase mTORHomo sapiens (human)
dendriteSerine/threonine-protein kinase mTORHomo sapiens (human)
TORC1 complexSerine/threonine-protein kinase mTORHomo sapiens (human)
TORC2 complexSerine/threonine-protein kinase mTORHomo sapiens (human)
phagocytic vesicleSerine/threonine-protein kinase mTORHomo sapiens (human)
nuclear envelopeSerine/threonine-protein kinase mTORHomo sapiens (human)
nucleusSerine/threonine-protein kinase mTORHomo sapiens (human)
cytoplasmSerine/threonine-protein kinase mTORHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (80)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID351876Binding affinity to Mycobacterium tuberculosis His4-tagged recombinant CYP51 substrate binding site expressed in Escherichia coli HMS174(DE3) by UV-visible spectral titration method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.
AID1616275Binding affinity to human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed induction of shift in Soret peak in phosphate buffer at 200 uM measured up to 6 hrs by UV-vis absorption spectroscopy (Rvb = 403 nm)2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID1059426Binding affinity to recombinant human ferric form of IDO1 using SYPRO orange dye by differential scanning fluorimetry analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID1616274Effect on full-length human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed as protection against enzyme degradation by measuring increase in kynurenine production level at 5 to 25 uM in presence of ascorbate and MB reductants pre-incubated for 2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID1659826Inhibition of IMPDH (unknown origin)2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Molecule Property Analyses of Active Compounds for
AID69097Dissociation constant when binding to FK506 binding protein (FKBP).1999Journal of medicinal chemistry, Jul-15, Volume: 42, Issue:14
Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein.
AID1453712Inhibition of human IDO expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of kynurenine production using L-tryptophan as substrate after 30 mins2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
AID1440295Inhibition of full length recombinant human His-tagged IDO1 expressed in mouse LLTC cells using L-tryptophan as substrate after 24 hrs2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID38395Inhibition of Aminopyrine N-demethylase in Phenobarbitone-treated rats1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Inhibitors of hepatic mixed-function oxidases. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats.
AID1440285Inhibition of recombinant human IDO1 expressed in bacterial expression system using L-Tryptophan as substrate after 25 mins in presence of GSH and tween20 by fluorescence assay2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID6996Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 10 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1440272Selectivity ratio of IC50 for recombinant human IDO1 S167A mutant expressed in Escherichia coli SG13009(pREP4) to IC50 for recombinant human IDO1 expressed in bacterial expression system2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID1713751Inhibition of human IDO12016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation.
AID6999Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 20 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID208345Enhancement of styrene hydrolase activity was determined in male wistar rat hepatic microsomes given to 3-methylcholanthrene treated rats.1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Structural features of imidazole derivatives that enhance styrene oxide hydrolase activity in rat hepatic microsomes.
AID1390975Inhibition of Mycobacterium tuberculosis IMPDH deltaCBS mutant assessed as reduction in NADH production at 1 mM using IMP as substrate preincubated for 5 mins followed by substrate addition measured for 32 mins in presence of NAD+2018Journal of medicinal chemistry, 04-12, Volume: 61, Issue:7
Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
AID208347Enhancement of styrene hydrolase activity was determined in male wistar rat hepatic microsomes given to phenobarbital treated rats.1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Structural features of imidazole derivatives that enhance styrene oxide hydrolase activity in rat hepatic microsomes.
AID1440292Reversible inhibition of recombinant human IDO1 expressed in bacterial expression system assessed as residual activity at 400 uM using L-Tryptophan as substrate after preincubated for 90 mins followed by 100 fold compound dilution measured after 15 mins b2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID7006Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 100 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1616288Effect on full-length human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed as kynurenine production level at 25 uM pre-incubated for 120 mins before L-Trp addition by HPLC analysis relative to control2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID184443Interaction with cytochrome P450 in Phenobarbitone-induced rat hepatic microsomes1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Inhibitors of hepatic mixed-function oxidases. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats.
AID1220389Binding affinity to C-terminal His4-tagged CYP2B4 dH/H226Y mutant (unknown origin) after 2 hrs by isothermal titration calorimetric analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Structure and function of cytochromes P450 2B: from mechanism-based inactivators to X-ray crystal structures and back.
AID6990Compound was evaluated for inhibition constant, in liver microsomes from beta-naphthoflavone-exposed rats1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1557382Inhibition of rabbit small intestine IDO1 expressed in COS1 cells assessed as reduction in kynurenine formation using L-Trp or D-Trp as substrate2019MedChemComm, Oct-01, Volume: 10, Issue:10
Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID1350379Inhibition of human IDO1 expressed in Escherichia coli BL21 (DE3) using L-tryptophan as substrate2018ACS medicinal chemistry letters, Feb-08, Volume: 9, Issue:2
Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold.
AID361931Inhibition of human recombinant indoleamine 2,3-dioxygenase by Eadie-Hofstee plot2008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
AID1440268Inhibition of recombinant human IDO1 expressed in bacterial expression system at 20 uM using L-Tryptophan as substrate after 25 mins by fluorescence assay relative to control2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID39082Effect on Aryl hydrocarbon hydroxylase activity in 3-methylcolanthrene-induced rat liver microsomes at 4.3x10E-4M1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Inhibitors of hepatic mixed-function oxidases. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats.
AID687184Dissociation constant, pKa of the compound at pH 2 to 3 by spectrophotometric analysis2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
AID687185Dissociation constant, pKa of the compound at pH 11 to 12 by spectrophotometric analysis2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
AID1440271Inhibition of recombinant human IDO1 S167A mutant expressed in Escherichia coli SG13009(pREP4) using L-Tryptophan as substrate after 25 mins by fluorescence assay2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID1616272Dissociation constant, pKa of the compound2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID7019Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1616277Binding affinity to human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed protection against heme degradation at 200 uM in presence of ascorbate and MB reductants by UV-vis absorption spectroscopy2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID6975Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID7021Compound was evaluated for alpha -rate constant, in liver microsomes from 3-methylcholanthrene-exposed rats1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID7298Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 20 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID728969Inhibition of human recombinant N-terminus 6X-histidine-tagged indoleamine 2,3-dioxygenase expressed in Escherichia coli assessed as inhibition of L-tryptophan to N-formylkynurenine formation measured as residual enzyme activity incubated for 15 mins prio2013Journal of medicinal chemistry, Apr-25, Volume: 56, Issue:8
Aminophenoxazinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis of exfoliazone and chandrananimycin A.
AID6977Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 100 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1252323Inhibition of IDO1 (unknown origin)2015Journal of medicinal chemistry, Nov-25, Volume: 58, Issue:22
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
AID184441Interaction with cytochrome P450 in 3-methylcholanthrene-induced rat hepatic microsomes1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Inhibitors of hepatic mixed-function oxidases. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats.
AID1616271Inhibition of IDO1 in IFN-gamma-stimulated human HeLa cells assessed as decrease in kynurenine levels after 48 hrs2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID1616289Effect on full-length human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed as protection against enzyme degradation by measuring increase in kynurenine production level at 5 to 25 uM in presence of ascorbate and MB reductants and catalase pre-i2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID1775066Cytotoxicity against human HEK293T cells assessed as reduction in cell viability at 200 uM after 7 hrs by DAPI staining based assay2021Journal of medicinal chemistry, 02-25, Volume: 64, Issue:4
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
AID1267460Inhibition of recombinant N-terminal truncated human cytosolic 5'-nucleotidase-2 assessed as inhibition of inosine 5'-monophosphate hydrolysis at 1 mM by rapid green malachite assay2015Journal of medicinal chemistry, Dec-24, Volume: 58, Issue:24
Identification of Noncompetitive Inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach.
AID1616276Binding affinity to human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed induction of shift in Soret peak in phosphate buffer at 200 uM in presence of ascorbate and MB reductants by UV-vis absorption spectroscopy2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID1059425Binding affinity to recombinant human ferrous form of IDO1 using SYPRO orange dye by differential scanning fluorimetry analysis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID1440289Reversible inhibition of recombinant human IDO1 expressed in bacterial expression system at 400 uM using L-Tryptophan as substrate after preincubated for 90 mins followed by 100 fold compound dilution measured after 15 mins by fluorescence assay relative 2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID7296Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 10 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID7297Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 1 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID208349Enhancement of styrene hydrolase activity was determined in male wistar rat hepatic microsomes given to untreated rats.1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Structural features of imidazole derivatives that enhance styrene oxide hydrolase activity in rat hepatic microsomes.
AID594946Inhibition of human ASIC3 expressed in HEK293 cells assessed as inhibition of acid-evoked current at 1000 uM by manual patch-clamp electrophysiology assay2011Bioorganic & medicinal chemistry letters, May-01, Volume: 21, Issue:9
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors.
AID1616270Effect on full-length human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed as kynurenine production level at 5 uM pre-incubated for 120 mins before L-Trp addition by HPLC analysis relative to control2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID1569323Inhibition of purified human IDO1 using L-tryptophan as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by spectrophotometric method2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Discovery of Clinical Candidate (1
AID39088Inhibition of Aryl hydrocarbon hydroxylase in phenobarbitone-treated rats1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Inhibitors of hepatic mixed-function oxidases. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats.
AID1775064Inhibition of recombinant human IDO1 expressed in Escherichia coli Rosetta (DE3) cells assessed as reduction in kynurenine production using L-tryptophan as substrate incubated for 20 mins by HPLC analysis2021Journal of medicinal chemistry, 02-25, Volume: 64, Issue:4
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
AID1440284Inhibition of recombinant human IDO1 expressed in bacterial expression system using L-Tryptophan as substrate after 25 mins in absence of GSH and tween20 by fluorescence assay2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID1440267Inhibition of recombinant human IDO1 expressed in bacterial expression system using L-Tryptophan as substrate after 25 mins in absence of GSH and presence of tween20 by fluorescence assay2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID6998Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 1 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1616273Basicity constant, pKb of the compound2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID7022Compound was evaluated for alpha -rate constant, in liver microsomes from beta-naphthoflavone-exposed rats1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1440298Selectivity ratio of IC50 for full length recombinant human His-tagged IDO1 expressed in mouse LLTC cells to IC50 for recombinant human IDO1 expressed in bacterial expression system in absence of GSH and presence of tween202017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID1616269Inhibition of full-length human IDO1 expressed in Escherichia coli Rosetta (DE3) using L-Trp substrate by HPLC analysis2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).
AID6989Compound was evaluated for inhibition constant, in liver microsomes from 3-methylcholanthrene-exposed rats1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1775067Inhibition of recombinant human IDO1 expressed in Escherichia coli Rosetta (DE3) cells assessed as reduction in kynurenine production using L-tryptophan as substrate at pH 7.4 incubated for 20 mins by HPLC analysis2021Journal of medicinal chemistry, 02-25, Volume: 64, Issue:4
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
AID7005Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID361932Inhibition of human recombinant indoleamine 2,3-dioxygenase in presence of D-tryptophan substrate2008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
AID1659809Antimycobacterial activity against Mycobacterium tuberculosis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Molecule Property Analyses of Active Compounds for
AID1440296Cytotoxicity against mouse LLTC cells assessed as reduction in cell viability after 24 hrs by MTT assay2017European journal of medicinal chemistry, Jan-27, Volume: 126Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
AID6986Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities.
AID1882075Inhibition of IDO1 (unknown origin)2022European journal of medicinal chemistry, Jan-05, Volume: 227Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1799791Binding Assay from Article 10.1074/jbc.M110.164293: \\Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.\\2010The Journal of biological chemistry, Dec-03, Volume: 285, Issue:49
Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
AID1798457Enzyme Inhibition Assay from Article 10.1021/jm800512z: \\Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.\\2008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
AID1798586Ligand Binding Assay from Article 10.1128/AAC.00311-07: \\Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.\\2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.
AID1802600Optical Titration Assay from Article 10.1021/acs.biochem.6b00954: \\Fragment Profiling Approach to Inhibitors of the Orphan M. tuberculosis P450 CYP144A1.\\2017Biochemistry, 03-21, Volume: 56, Issue:11
Fragment Profiling Approach to Inhibitors of the Orphan M. tuberculosis P450 CYP144A1.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (15.38)18.7374
1990's5 (9.62)18.2507
2000's12 (23.08)29.6817
2010's22 (42.31)24.3611
2020's5 (9.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.85 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]